Moffitt at SITC

Pioneering Change for Cancer Patients

Moffitt Cancer Center's research focuses on cutting-edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances. As pioneers of immunotherapy as a groundbreaking cancer treatment, we are excited to participate in the Society for Immunotherapy of Cancer Annual Meeting November 4-8. The studies our scientists present explore many advances in areas like radiomics, checkpoint inhibitors and TIL therapy covering many cancer types.

Be sure to visit our Booth #901 to meet members of the team and learn more about the impact Moffitt is making in cancer research, outcomes and advancements. 

To learn more about Moffitt’s research and breakthroughs, follow Moffitt on LinkedIn and Twitter (@MoffittNews) or subscribe to one of our newsletters.

Full 2026 Video Playlist

Patrick Hwu, MD
President and CEO

Maryam Ayazi, PhD
Postdoctoral Fellow, Immunology 

Rana Falahat, PhD
Assistant Member, Imunology

Erick Saldanha, MD
Assistant Member, Cutaneous Oncology & Early Therapeutics Development Department

Peter Forsyth, MD
Chair, Neuro-Oncology

Achintyan Gangadharan, MS
Doctoral Candidate, Immunology

Fatema Khambati
Research Project Specialist, Immunology

Vincent Law, PhD
Senior Research Project Specialist

Tao Li, PhD
Applied Research Scientist

Kimberly Luddy, PhD
Research Scientist, Immunology

Olabisi Osunmakinde, MSc
Doctoral Candidate, Immunology

Renata Rossetti, PhD
Research Scientist, Immunology

Greg Sawyer, PhD
Chair, BioEngineering

Timothy Shaw, PhD
Assistant Member, Bioinfomatics

Ahmad Tarhini, MD, PhD
Senior Member, Cutaneous Oncology and Immunology

Kenneth Tsai, MD PhD
Vice Chair, Research Pathology